Experience the Benefits of "Jaumsaeng Cream"
with Generous Purchase Offers

Amorepacific announced on October 13 that its luxury beauty brand Sulwhasoo will hold the "Jaumsaeng Luxury Beauty Fair" from October 13 to November 2 across major online platforms and department stores nationwide.

Sulwhasoo Holds 'Jaumsaeng Luxury Beauty Fair'... "Trial Kits Available" View original image
Sulwhasoo Global Ambassador Im Yoonah. Provided by Amorepacific.

Sulwhasoo Global Ambassador Im Yoonah. Provided by Amorepacific.

View original image

This event is designed to promote the outstanding benefits of "Jaumsaeng Cream," Sulwhasoo's flagship product and the number one anti-aging cream for ten consecutive years, while strengthening customer engagement through a variety of purchase benefits.


During the fair, customers can directly experience Jaumsaeng Cream's ability to boost the skin’s natural vitality, and also explore a range of products from the Jaumsaeng line. Various promotional offers, including product trial kits, will be available for customers who make a purchase.


Exclusive Jaumsaeng special sets, available only at department stores, will also be introduced. In particular, customized benefits tailored to each distributor will offer customers a diverse shopping experience.


Sulwhasoo Jaumsaeng Cream combines proprietary ginseng ingredients developed over 60 years of research with advanced skin science, delivering remarkable effects in revitalizing the skin’s natural vitality. Its key ingredient, "Ginsenomics™," features rare ginseng saponins concentrated 6,000 times, which help promote collagen production within the skin and strengthen the skin barrier, enhancing elasticity and density.



A Sulwhasoo representative stated, "Through the Jaumsaeng Luxury Beauty Fair, which delivers the true benefits of Jaumsaeng Cream to our customers, we aim to create deeper connections with our customers."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing